open access

Vol 57, No 4 (2006)
Original papers
Published online: 2006-07-07
Submitted: 2013-02-15
Get Citation

Diagnostic scintigraphy and effectiveness of 131I radioiodine therapy in differentiated thyroid carcinoma (DTC)

Agata Bałdys-Waligórska, Monika Buziak-Bereza, Bohdan Huszno, Anna Wilczak
Endokrynologia Polska 2006;57(4):380-385.

open access

Vol 57, No 4 (2006)
Original papers
Published online: 2006-07-07
Submitted: 2013-02-15

Abstract

Introduction: Since the effect of pre-therapeutic scintigraphy on the outcome of DTC treatment is debated, we evaluated factors affecting the effectiveness of 131I therapy with respect to the delay between diagnostic scintigraphy and the application of radioiodine.
Material and methods: In the studied group of 60 patients with DTC, mean age 54.6 ± 13.0 years, four weeks prior to the planned diagnostics, L-thyroxine was withdrawn and the following tests performed: 131I (4 MBq) uptake above the neck, thyroid volume by USG, TSH and hTg level. Wholebody scintigraphy (37 MBq) was performed. The time between this diagnostic scintigraphy and application of 131I (3657 MBq) was calculated. Based on whole-body 131I scintigraphy (74 MBq) performed 1 year after radioiodine treatment, the patients were divided into: group I - 42 patients with no tracer accumulation, and group II - 18 patients who continued to accumulate 131I in the neck.
Results: The differences between the median values of 131I uptake and of thyroid volumes, and between the TSH and hTg median values in the two groups of patients were found not to be statistically significant. The average times between diagnostic scintigraphy and 131I treatment in group I and II (9.4 vs. 8.3 weeks, respectively) were not significantly different either.
Conclusion: Despite the different effectiveness of supplementary 131I treatment, patients in group I and group II showed no statistically significant differences in the studied parameters. It appears that the diagnostic 131I activity of 37 MBq and the time between diagnostic scintigraphy and application of 131I did not have any effect on the results of the treatment in our group of patients.

Abstract

Introduction: Since the effect of pre-therapeutic scintigraphy on the outcome of DTC treatment is debated, we evaluated factors affecting the effectiveness of 131I therapy with respect to the delay between diagnostic scintigraphy and the application of radioiodine.
Material and methods: In the studied group of 60 patients with DTC, mean age 54.6 ± 13.0 years, four weeks prior to the planned diagnostics, L-thyroxine was withdrawn and the following tests performed: 131I (4 MBq) uptake above the neck, thyroid volume by USG, TSH and hTg level. Wholebody scintigraphy (37 MBq) was performed. The time between this diagnostic scintigraphy and application of 131I (3657 MBq) was calculated. Based on whole-body 131I scintigraphy (74 MBq) performed 1 year after radioiodine treatment, the patients were divided into: group I - 42 patients with no tracer accumulation, and group II - 18 patients who continued to accumulate 131I in the neck.
Results: The differences between the median values of 131I uptake and of thyroid volumes, and between the TSH and hTg median values in the two groups of patients were found not to be statistically significant. The average times between diagnostic scintigraphy and 131I treatment in group I and II (9.4 vs. 8.3 weeks, respectively) were not significantly different either.
Conclusion: Despite the different effectiveness of supplementary 131I treatment, patients in group I and group II showed no statistically significant differences in the studied parameters. It appears that the diagnostic 131I activity of 37 MBq and the time between diagnostic scintigraphy and application of 131I did not have any effect on the results of the treatment in our group of patients.
Get Citation

Keywords

differentiated thyroid cancer; whole body scintigraphy

About this article
Title

Diagnostic scintigraphy and effectiveness of 131I radioiodine therapy in differentiated thyroid carcinoma (DTC)

Journal

Endokrynologia Polska

Issue

Vol 57, No 4 (2006)

Pages

380-385

Published online

2006-07-07

Bibliographic record

Endokrynologia Polska 2006;57(4):380-385.

Keywords

differentiated thyroid cancer
whole body scintigraphy

Authors

Agata Bałdys-Waligórska
Monika Buziak-Bereza
Bohdan Huszno
Anna Wilczak

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl